CCN family of proteins: critical modulators of the tumor cell microenvironment

被引:0
|
作者
Herman Yeger
Bernard Perbal
机构
[1] The Hospital for Sick Children,Program in Developmental & Stem Cell Biology, Research Institute
[2] Université Côte d’Azur,CNRS, GREDEG, International CCN Society
关键词
CCN proteins; Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
The CCN family of proteins consisting of CCN1 (Cyr61), CCN2 (CTGF), CCN3 (NOV), CCN4 (WISP-1), CCN5 (WISP-2) and CCN6 (WISP-3) are considered matricellular proteins operating essentially in the extracellular microenvironment between cells. Evidence has also been gradually building since their first discovery of additional intracellular roles although the major activity is triggered at the cell membrane. The proteins consist of 4 motifs, a signal peptide (for secretion} followed consecutively by the IGFBP, VWC, TSP1 and CT (C-terminal cysteine knot domain) motifs, which signify their potential binding partners and functional connections to a variety of key regulators of physiological processes. With respect to cancer it is now clear that, whereas certain members can facilitate tumor behavior and progression, others can competitively counter the process. It is therefore clear that the net outcome of biological interactions in the matrix and what gets signaled or inhibited can be a function of the interplay of these CCN 1–6 proteins. Because the CCN proteins further interact with other key proteins, like growth factors in the matrix, the balance is not only important but can vary dynamically with the physiological states of tumor cells and the surrounding normal cells. The tumor niche with its many cell players has surfaced as a critical determinant of tumor behavior, invasiveness, and metastasis. It is in this context that CCN proteins should be investigated with the potential of being recognized and validated for future therapeutic approaches.
引用
收藏
页码:229 / 240
页数:11
相关论文
共 50 条
  • [31] Deadly liaisons: fatal attraction between CCN matricellular proteins and the tumor necrosis factor family of cytokines
    Chih-Chiun Chen
    Lester F. Lau
    Journal of Cell Communication and Signaling, 2010, 4 : 63 - 69
  • [32] Regulation of T cell functions by cytoskeletal proteins in the melanoma tumor microenvironment
    Harikumar, N.
    Sharma, V.
    Platzer, R.
    Borik, L.
    Pfisterer, K.
    Petzelbauer, P.
    Menche, J.
    Hoeller, C.
    Dupre, L.
    Huppa, J.
    Bock, C.
    Stary, G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S359 - S359
  • [33] Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes
    Twigg, Stephen M.
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2018, 12 (01) : 359 - 368
  • [34] The CCN family of cell growth regulators: lessons from the first international workshop on the CCN family of genes
    Perbal, B
    BULLETIN DU CANCER, 2001, 88 (07) : 645 - 649
  • [35] Cloning, expression and purification of the CCN family of proteins in Escherichia coli
    Holbourn, Kenneth P.
    Acharya, K. Ravi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (04) : 837 - 841
  • [36] The CCN family of proteins: a 25th anniversary picture
    Perbal, Annick
    Perbal, Bernard
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2016, 10 (03) : 177 - 190
  • [37] Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes
    Stephen M. Twigg
    Journal of Cell Communication and Signaling, 2018, 12 : 359 - 368
  • [38] Adipocytes as a critical component of the tumor microenvironment
    Vona-Davis, Linda
    Gibson, Laura F.
    LEUKEMIA RESEARCH, 2013, 37 (05) : 483 - 484
  • [39] The CCN family of proteins: a 25th anniversary picture
    Annick Perbal
    Bernard Perbal
    Journal of Cell Communication and Signaling, 2016, 10 : 177 - 190
  • [40] ONCOLYTIC VIRUS AND TUMOR MICROENVIRONMENT MODULATORS AN ALLIANCE TO FIGHT GLIOBLASTOMA
    Puigdelloses, M.
    Martinez-Velez, N.
    Garcia-Moure, M.
    Gonzalez-Huarriz, M.
    Inigo, I.
    Marta, A. M.
    Gallego Perez-Larraya, J.
    NEURO-ONCOLOGY, 2019, 21 : 56 - 56